+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Diabetes Care Devices Market Research Report by Use (Point-of-care and Selftest), Product, Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5311206
  • Report
  • April 2022
  • Region: Global
  • 206 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Diabetes Care Devices Market size was estimated at USD 1,870.82 million in 2021, USD 2,213.30 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 18.48% to reach USD 5,175.80 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Diabetes Care Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Use, the market was studied across Point-of-care and Selftest.
  • Based on Product, the market was studied across Blood Glucose Monitoring Devices and Insulin Delivery Devices. The Blood Glucose Monitoring Devices is further studied across Continuous Glucose Monitors, Lancets, Self-Monitoring Blood Glucose Meters, and Testing Strips. The Insulin Delivery Devices is further studied across Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.
  • Based on Distribution, the market was studied across Offline Mode and Online Mode.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Diabetes Care Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diabetes Care Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diabetes Care Devices Market, including Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Arkray, Inc., B. Braun Melsungen AG, Becton, Dickinson, and Company, Bionime, DexCom, Inc., Diabeloop SA., Echo Therapeutics, Inc, Eli Lilly and Company, F.Hoffmann-La Roche AG, Glysens Incorporated, Insulet Corporation, Johnson & Johnson Services, Inc, Medisana, Medtronic PLC, Nova Biomedical, Inc, Novo Nordisk A/S, PHC Holdings Corporation, Rossmax International Ltd., Sanofi S.A., Sinocare, Inc., Terumo Corporation, Wockhardt Limited, and Ypsomed Holding AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Diabetes Care Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diabetes Care Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diabetes Care Devices Market?
4. What is the competitive strategic window for opportunities in the Global Diabetes Care Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Diabetes Care Devices Market?
6. What is the market share of the leading vendors in the Global Diabetes Care Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Diabetes Care Devices Market?
Frequently Asked Questions about the Global Diabetes Care Devices Market

What is the estimated value of the Global Diabetes Care Devices Market?

The Global Diabetes Care Devices Market was estimated to be valued at $1870.8 Million in 2021.

What is the growth rate of the Global Diabetes Care Devices Market?

The growth rate of the Global Diabetes Care Devices Market is 18.4%, with an estimated value of $5175.8 Million by 2027.

What is the forecasted size of the Global Diabetes Care Devices Market?

The Global Diabetes Care Devices Market is estimated to be worth $5175.8 Million by 2027.

Who are the key companies in the Global Diabetes Care Devices Market?

Key companies in the Global Diabetes Care Devices Market include Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Arkray, Inc., B. Braun Melsungen AG, Becton, Dickinson, and Company, Bionime, DexCom, Inc. and Echo Therapeutics, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing diabetic population and rising awareness of diabetes treatment
5.1.1.2. Rising need for new technologies such as glucose level monitoring
5.1.1.3. Supportive government initiatives for diabetic care
5.1.2. Restraints
5.1.2.1. High cost associated with advanced medical devices
5.1.3. Opportunities
5.1.3.1. Increasing trend of self care or home care
5.1.3.2. Improved functionality with integration of advanced technologies
5.1.3.3. Increasing mHealth applications
5.1.4. Challenges
5.1.4.1. Lack of awareness and penetration in underdeveloped areas
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Diabetes Care Devices Market, by Use
6.1. Introduction
6.2. Point-of-care
6.3. Selftest
7. Diabetes Care Devices Market, by Product
7.1. Introduction
7.2. Blood Glucose Monitoring Devices
7.2.1. Continuous Glucose Monitors
7.2.2. Lancets
7.2.3. Self-Monitoring Blood Glucose Meters
7.2.4. Testing Strips
7.3. Insulin Delivery Devices
7.3.1. Insulin Jet Injectors
7.3.2. Insulin Pens
7.3.3. Insulin Pumps
7.3.4. Insulin Syringes
8. Diabetes Care Devices Market, by Distribution
8.1. Introduction
8.2. Offline Mode
8.3. Online Mode
9. Americas Diabetes Care Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Diabetes Care Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Diabetes Care Devices Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Acon Laboratories, Inc.
13.3. AgaMatrix, Inc.
13.4. Arkray, Inc.
13.5. B. Braun Melsungen AG
13.6. Becton, Dickinson, and Company
13.7. Bionime
13.8. DexCom, Inc.
13.9. Diabeloop SA.
13.10. Echo Therapeutics, Inc
13.11. Eli Lilly and Company
13.12. F.Hoffmann-La Roche AG
13.13. Glysens Incorporated
13.14. Insulet Corporation
13.15. Johnson & Johnson Services, Inc
13.16. Medisana
13.17. Medtronic PLC
13.18. Nova Biomedical, Inc
13.19. Novo Nordisk A/S
13.20. PHC Holdings Corporation
13.21. Rossmax International Ltd.
13.22. Sanofi S.A.
13.23. Sinocare, Inc.
13.24. Terumo Corporation
13.25. Wockhardt Limited
13.26. Ypsomed Holding AG
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL DIABETES CARE DEVICES MARKET: DYNAMICS
FIGURE 2. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2027
FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2027
FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 33. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 35. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. AMERICAS DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. BRAZIL DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. CANADA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. MEXICO DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. CHINA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. INDIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. INDONESIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. JAPAN DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. TAIWAN DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. THAILAND DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. FRANCE DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. GERMANY DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. ITALY DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. QATAR DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. RUSSIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. SPAIN DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. GLOBAL DIABETES CARE DEVICES MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL DIABETES CARE DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIABETES CARE DEVICES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY STATE, 2019-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. BRAZIL DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. CANADA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. MEXICO DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. CHINA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. INDIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. INDONESIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. JAPAN DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. TAIWAN DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. THAILAND DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. FRANCE DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. GERMANY DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. ITALY DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. QATAR DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. RUSSIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. SPAIN DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. GLOBAL DIABETES CARE DEVICES MARKET: SCORES
TABLE 107. GLOBAL DIABETES CARE DEVICES MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL DIABETES CARE DEVICES MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL DIABETES CARE DEVICES MARKET: RANKING
TABLE 110. GLOBAL DIABETES CARE DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 111. GLOBAL DIABETES CARE DEVICES MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL DIABETES CARE DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL DIABETES CARE DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL DIABETES CARE DEVICES MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL DIABETES CARE DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 116. GLOBAL DIABETES CARE DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Bionime
  • DexCom, Inc.
  • Diabeloop SA.
  • Echo Therapeutics, Inc
  • Eli Lilly and Company
  • F.Hoffmann-La Roche AG
  • Glysens Incorporated
  • Insulet Corporation
  • Johnson & Johnson Services, Inc
  • Medisana
  • Medtronic PLC
  • Nova Biomedical, Inc
  • Novo Nordisk A/S
  • PHC Holdings Corporation
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare, Inc.
  • Terumo Corporation
  • Wockhardt Limited
  • Ypsomed Holding AG

Methodology

Loading
LOADING...